Speaking in May 2019, Dr Dajun Yang, chairman, executive director and CEO of Ascentage Pharma, shares the company’s top highlights over the past decade; their strong product pipeline and portfolio of innovative therapeutics focusing on protein-protein interactions (PPIs); and their global strategy to become an international, world-class biotech company.
Today, we are the world’s second-largest pharma market. I hope that in a decade or two, China will also become the world’s second-most innovative pharma market
